Skip to main content
. 2015 Feb 5;2015:689531. doi: 10.1155/2015/689531

Table 1.

Predictors of brand name proton pump inhibitor choice among patients prescribed a proton pump inhibitor, 2006–2010.

Total unweighted sample
(N = 9,677)
Weighted encounters with a brand name PPI, millions (%) P value Adjusted incidence rate ratio (95% CI) of brand name PPI
Year
 2006 1753 43.1 (76.0) <0.0001 Ref
 2007 2011 46.2 (74.3) 1.0 (0.9-1.0)
 2008 1665 31.8 (51.0) 0.7 (0.6-0.7)
 2009 2153 33.3 (42.0) 0.6 (0.5-0.6)
 2010 2095 21.7 (31.6) 0.4 (0.4-0.5)
Age category, y
 18–24 yrs 144 2.2 (46.1) 0.004 Ref
 25–44 yrs 1383 26.9 (57.9) 1.2 (0.9–1.5)
 45–64 yrs 3766 70.0 (55.4) 1.2 (0.9–1.5)
 ≥65 yrs 4384 76.9 (50.7) 1.1 (0.9–1.4)
Sex
 Female 5857 111.4 (55.1) 0.004 Ref
 Male 3820 64.6 (50.9) 0.9 (0.9-1.0)
Race/ethnicity
 White 7478 133.3 (51.4) 0.001 Ref
 Black 862 17.6 (59.8) 1.1 (1.0–1.2)
 Hispanic/Latino 972 12.4 (38.8) 1.1 (1.0–1.2)
 Other 365 5.6 (51.4) 1.0 (0.8–1.1)
Median Income
 Q1 (<32.8 K) 2091 37.5 (57.0) 0.2
 Q2 (32.8–40.6) 2340 42.7 (53.2)
 Q3 (>40.6–52.4) 2375 42.9 (52.7)
 Q4 (>52.4) 2339 42.6 (51.5)
Region
 South 3318 80.0 (60.0) <0.0001 Ref
 Northeast 1916 34.7 (53.8) 0.9 (0.8–1.0)
 Midwest 2515 34.6 (45.8) 0.8 (0.7–0.9)
 West 1928 26.8 (47.9) 0.8 (0.8-0.9)
Patient insurance type
 Private 3920 77.3 (54.3) 0.1
 Medicare 4009 71.1 (51.4)
 Medicaid 839 13.7 (58.3)
 Other 615 9.0 (56.8)
 Unknown 294 4.9 (53.2)
Total number of chronic conditions
 0 1917 36.6 (56.5) 0.0001 Ref
 1-2 4610 86.9 (55.5) 1.0 (1.0-1.1)
 ≥3 3150 52.6 (48.8) 0.9 (0.9-1.0)
Provider type
 Primary care 4426 95.0 (50.9) 0.002 Ref
 Medical spec. 3436 59.0 (57.1) 1.1 (1.0–1.2)
 Surgical spec. 1815 22.1 (56.0) 1.1 (1.0-1.1)
Practice ownership
 HMO 217 0.7 (13.8) <0.0001 Ref
 Physician-owned 7174 148.9 (55.6) 3.6 (2.0–6.4)
 Community health center 982 4.0 (52.5) 3.7 (2.0–6.7)
 Academic medical center 197 3.9 (58.9) 4.0 (2.2–7.3)
 Other 1093 17.8 (43.4) 3.2 (1.8–5.6)
Metropolitan status of practice
 MSA 8342 151.3 (53.7) 0.6
 Non-MSA 1335 24.7 (52.2)

As a percentage of the total number of patients prescribed a PPI, adjusted for sample weights.